News & Press Releases

< back to News & Press Releases

Date: Apr 29 2010

Lifetree Clinical Research® to exhibit at 29th Annual Scientific Meeting of the American Pain Society

LIFETREE CLINICAL RESEARCH® TO EXHIBIT AT  

29th ANNUAL SCIENTIFIC MEETING OF THE AMERICAN PAIN SOCIETY

 

 

Salt Lake City-Lifetree Clinical Research® and Lifetree Center for Neuroscience Research, one of the largest specialized clinical research organizations in the Western region of the United States, will participate as an exhibitor at the 29th Annual Scientific Meeting of the American Pain Society (APS) May 6 through 8 in Baltimore, Md.  Lifetree chief medical director and lead investigator, Lynn R. Webster M.D., will also present three posters, moderate the closing general session and present in a Saturday symposium.    

 

"We are looking forward to participating in the upcoming APS meeting.  It is always a great arena for interdisciplinary exchange with our peers and clients,” said Lifetree Clinical Research CEO Alice Jackson.  "Since 2003, Lifetree has steadfastly promoted the growing need for better pain-management solutions, and this meeting provides a perfect platform for Lifetree to showcase our specialized services.  Dr. Webster is highly respected and a published thought leader in pain and abuse liability.  His clinical research projects at Lifetree have produced important results on pain and pain mechanisms, substance abuse, addiction and the use of chronic pain medication and the impact these medications have on sleep.  His participation in the meeting provides great insight to interdisciplinary leaders.”   

 

Attendees are invited to stop by the Lifetree booth (# 211) to meet the Lifetree management team and learn about the specialized services Lifetree offers.  Lifetree Clinical Research® now provides a broader range of central nervous system-related investigations with the formation of Lifetree Center for Neuroscience Research in April of 2008.  The company also provides experimental drug development expertise for clients utilizing three human experimental pain models to assess the efficacy of new analgesic drugs:  Cold Pressor, Neurometer®/QST, and Heat/Capsaicin.

 

Lifetree Clinical Research® offers multi-therapeutic clinical trials management (CTM) and site expertise in phase I-III clinical trials, with a unique approach to phase I, abuse liability, central nervous system and analgesia.   Lifetree Clinical Research® is strategically integrated with Lifetree Pain Clinic in a seamless 25,000-square-foot, 60-bed facility and offers advanced expertise in first-in-human/MTD, bioavailability and bioequivalence, PK/PD/proof of concept, innovative pain model development and Cerebral Spinal Fluid sampling.  Site services include PET Scanning, MRS and FMRI Capabilities and on-site pharmacy capable of handling all scheduled drugs I –V. 

 

  For more detailed information about Lifetree Clinical Research®, please visit www.lifetreeresearch.com